Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,639 | 17,043 | 18,943 | 11,815 | 13,693 |
| Receivables | 1,377 | 1,369 | 1,665 | 1,674 | 2,459 |
| TOTAL | $17,434 | $19,071 | $21,735 | $14,768 | $16,993 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $17,434 | $19,071 | $21,735 | $14,768 | $16,993 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,001 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,914 | 1,299 | 1,993 | 2,925 | 2,090 |
| TOTAL | $3,638 | $2,274 | $3,346 | $4,278 | $2,501 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 723 | 975 | 1,353 | 1,353 | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,638 | $2,274 | $3,346 | $4,278 | $2,501 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16,673 | 16,673 | 16,673 | 12,939 | 11,315 |
| Common Shares | 17 | 17 | 17 | 11 | 11 |
| Retained earnings | -462,360 | -459,181 | -457,478 | -455,479 | -451,463 |
| TOTAL | $13,796 | $16,797 | $18,389 | $10,490 | $14,492 |
| Total Liabilities And Equity | $17,434 | $19,071 | $21,735 | $14,768 | $16,993 |